Dana Razzano, MD | Stanford Pathology

10/10/22 • 37 min

Dana Razzano is a GI, liver, and cytopathologist at Stanford and also a faculty fellow at the Stanford Center for Innovation in Global Health. She has dedicated her work in pathology to improving access to laboratory medicine services in low and middle income countries. Dr. Razzanno joins Beyond The Scope to discuss her model for training pathologists around the globe, including a newly launched training program in Ethiopia. Furthermore, she discusses how digital pathology can help increase the pathology workforce and improve patient access to pathology services globally. For more information on Dr. Razzano's work and how to get involved, please visit: https://pathinfo.fandom.com/wiki/Global_Health_Opportunities_for_Pathologists. Dr. Razzano also delivers a newsletter to laboratory medicine professionals in low and middle income countries featuring grant, workshop, and training opportunities. Sign up for the newsletter here: https://lp.constantcontactpages.com/su/lhFaaUN/GlobalPathology.

A forum to engage with the hosts and other listeners has been launched on the DPA website www.digitalpathologyassociation.org. DPA members may login to the DPA Collaborate hub (under the Resources tab) and join the Beyond The Scope community. All listeners are encouraged to use this forum to suggest future topics and guests, submit questions and corrections, and provide general feedback.

Send us a text

Previous Episode

Global Digital Pathology Task Force

Send us a text

This special episode of Beyond The Scope features a panel discussion with the 3 current Presidents of Digital Pathology societies on 3 different continents. Junya Fukuoka MD, PhD is a lung pathologist and President of the Japanese Society of Digital Pathology. Norman Zerbe is a computer scientist and President of the European Society of Digital and Integrative Pathology. Esther Abels is a clinical and regulatory expert and President of the Digital Pathology Association in North America. Topics included in the panel discussion are: 1) The state of DP/AI adoption on each continent, 2) Ethical and regulatory considerations surrounding new pathology technology, 3) Standards for emerging technologies, and 4) Advice to pathologists and vendors looking to move the industry forward.

Next Episode

Staci Kearney, PhD | Elevation Strategic Development

Send us a text

Dr. Staci Kearney is a regulatory consultant and Founder of Elevation Strategic Development. She joins the show to discuss her unique path to the regulatory field as someone with a scientific background. In the last 5 years, the DP/AI industry has experienced the milestones of the first whole slide imaging system approved for primary diagnosis and the first AI algorithm approved as an aid to diagnosis. Dr. Kearney discusses the role of regulatory professionals in the industry and outlines the areas where vendors typically seek assistance from consultants. Finally, with the legislation surrounding In Vitro Diagnostics and DP/AI rapidly changing, Dr. Kearney breaks down the most impactful regulatory updates.